Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Di-p-toluoyl-d-tartaric Acid
2. Di-p-toluoyltartaric Acid
1. 32634-68-7
2. Di-p-toluoyl-d-tartaric Acid
3. (+)-di-1,4-toluoyl-d-tartaric Acid
4. (2s,3s)-2,3-bis((4-methylbenzoyl)oxy)succinic Acid
5. (+)-o,o'-di-p-toluoyl-d-tartaric Acid
6. Ditoluoyltartaric Acid, (+)-
7. (2s,3s)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic Acid
8. (+)-dtta
9. Mfcd00008552
10. (+)-ditoluoyltartaric Acid
11. (2s,3s)-2,3-bis[(4-methylbenzoyl)oxy]succinic Acid
12. 4480ma5qip
13. (+)-di-p-toluoyl-d-tartaric Acid
14. Di-p-toluoyl-l-tartaric Acid
15. Nsc-97592
16. (+)-di-(p-toluoyl)-d-tartaric Acid
17. (+)-di-o-p-toluoyl-d-tartaric Acid
18. [s(r*,r*)]-2,3-bis[(4-methylbenzoyl)oxy]succinic Acid
19. (+)-di-p-toluoyl-d-(+)-tartaric Acid
20. Butanedioic Acid, 2,3-bis((4-methylbenzoyl)oxy)-, (2s,3s)-
21. O,o'-di-p-toluoyl-d-tartaric Acid
22. (s(r*,r*))-2,3-bis((4-methylbenzoyl)oxy)succinic Acid
23. Unii-4480ma5qip
24. D-dtta
25. D-ptta
26. (+)-di-o,o'-p-toluyl-d-tartaric Acid
27. Nsc97592
28. Einecs 251-132-2
29. Nsc 97592
30. Di-p-toluoyl-d-tartaricacid
31. Schembl72682
32. Mls001165767
33. (+)-o,o Inverted Exclamation Mark -di-p-toluoyl-d-tartaric Acid
34. Chembl1490343
35. D-(+)-di-p-toluoyltartaric Acid
36. Dtxsid80885539
37. Hms2855f10
38. D-(+)-di-p-toluoyl-tartaric Acid
39. Act02733
40. Str08702
41. Zinc1632794
42. Di-(4-methyl)benzoyl-d-tartaric Acid
43. Akos000278447
44. Rivastigmine Related Compound A
45. Cs-w020568
46. Di-p-toluoyl-d-tartaric Acid Anhydrous
47. Ks-1018
48. (s,s)-o,o'-di-p-toluoyltartaric Acid
49. D-di-o,o'-p-toluyltartaric Acid
50. Ac-13647
51. Smr000550472
52. Sy004755
53. (+)-o,o'-di-1,4-toluoyl-d-tartaric Acid
54. Am20060204
55. D1417
56. D-(+)-tartaric Acid-o,o'-di-p-toluoyl Ester
57. D-bis(o-4-methylbenzoyl)tartaric Acid
58. O,o'-di-p-toluoyl-d-tartaric Acid Anhydrous
59. (2s,3s)-(+)-di-o-4-toluoyl-d-tartaric Acid
60. 34d687
61. Rivastigmine Related Compound A [usp-rs]
62. (2s,3s)-2,3-bis(4-methylbenzoyloxy)succinic Acid
63. O,o'-di-p-toluoyl-d-tartaric Acid, (+)-
64. Q-201014
65. (2s,3s)-2,3-bis[(4-methybenzoyl)oxy]succinic Acid
66. Q27258721
67. Rivastigmine Related Compound A [usp Impurity]
68. (2s,3s)-2,3-bis-(4-methyl-benzoyloxy)-succinic Acid
69. (+)-o,o'-di-p-toluoyl-d-tartaric Acid, Purum, >=98.0%
70. (2s,3s)-(+)-2,3-bis[(4-methylbenzoyl)oxy]butane-1,4-dioic Acid
71. (+)-o,o'-di-p-toluoyl-d-tartaric Acid, Made From Synthetic Tartaric Acid, 97%
72. Rivastigmine Related Compound A, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 386.4 g/mol |
---|---|
Molecular Formula | C20H18O8 |
XLogP3 | 3.3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 9 |
Exact Mass | 386.10016753 g/mol |
Monoisotopic Mass | 386.10016753 g/mol |
Topological Polar Surface Area | 127 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 533 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?